EPO’s G3/19: no turning back?
The EPO’s May 2020 decision in G3/19, on the patentability of certain plants, was among the most controversial in the office’s history. Anna Gregson of Mathys & Squire explores the implications.
Latest news
Federal Circuit rules CardioNet patents 'abstract ideas'
03-07-2020
US medical technology company CardioNet has lost an appeal at the US Court of Appeals for the Federal Circuit , which found its patents covered abstract concepts and therefore are invalid.
50 Key Influencers In The Life Sciences
- LSIPR 50 2018: Robert Nelsen 05-09-2018
- LSIPR 50 2018: Stephen Knight 04-09-2018
Regions
Sectors
